Forschung & Innovation
Publikationen
From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.
PMU Autor*innen
Andrea Harrer, Georg Pilz, Katrin Oppermann, Elisabeth Haschke-Becher, Mark R. McCoy, Wolfgang Hitzl, Eugen Trinka, Jörg Kraus, Johann Sellner, Peter Wipfler
Alle Autor*innen
Andrea Harrer, Georg Pilz, Katrin Oppermann, Marlene Sageder, Shahrzad Afazel, Elisabeth Haschke-Becher, Theo Rispens, Annick de Vries, Mark R. McCoy, Vlado Stevanovic, Wolfgang Hitzl, Eugen Trinka, Jörg Kraus, Johann Sellner, Peter Wipfler
Fachzeitschrift
CLINICAL IMMUNOLOGY
Kurzfassung
Keywords
PLACEBO-CONTROLLED TRIAL, EFFICACY, ORAL FINGOLIMOD, FTY720, RELAPSING MULTIPLE-SCLEROSIS, DISEASE-ACTIVITY, IMMUNE, TIME, SATURATION, WITHDRAWAL